Works by Ogino, Yasuko


Results: 3
    1
    2
    3

    Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard‐dose azacitidine.

    Published in:
    Cancer Reports, 2024, v. 7, n. 1, p. 1, doi. 10.1002/cnr2.1938
    By:
    • Ogawa, Shinichi;
    • Sakamoto, Tatsuhiro;
    • Matsuoka, Ryota;
    • Ishitsuka, Kantaro;
    • Ogino, Yasuko;
    • Sootome, Ayano;
    • Makishima, Kenichi;
    • Yoshida, Chikashi;
    • Ito, Yufu;
    • Shimizu, Seiichi;
    • Suyama, Takuya;
    • Shinagawa, Atsushi;
    • Ito, Takayoshi;
    • Obara, Naoshi;
    • Kusakabe, Manabu;
    • Sakata‐Yanagimoto, Mamiko;
    • Miyazaki, Yasushi;
    • Nannya, Yasuhito;
    • Chiba, Shigeru
    Publication type:
    Article